New literature to help establish evidence-based practice in pediatric transfusion medicine was just published. The Pediatric Critical Care Transfusion and Anemia Expertise Initiative (TAXI) recently published guidelines to direct red blood cell (RBC) transfusion decision making in critically ill children. Similarly, a recent trial looked at outcomes of neonates receiving platelet transfusions at a threshold of 25x109/L. Lastly, the safety of pathogen reduced platelets in the pediatric population, especially neonates, is area of concern which was recently addressed. The session will review these new publications and provide recommendations for pediatric transfusion medicine practice in the areas of RBC transfusions, platelets transfusions and the considerations for the use of pathogen reduced platelets in this unique population.
Interpret the recent RBC transfusion guidelines published by the Pediatric Critical Care Transfusion and Anemia Expertise Initiative (TAXI).
Incorporate platelet transfusion guidelines for neonates into the transfusion service practice.
Assess the use & safety of pathogen reduced platelets in the pediatric population.